These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38926773)
21. Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype. Popp J; Lewczuk P; Frommann I; Kölsch H; Kornhuber J; Maier W; Jessen F J Alzheimers Dis; 2010; 22(2):459-68. PubMed ID: 21084733 [TBL] [Abstract][Full Text] [Related]
22. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers. Park MK; Ahn J; Kim YJ; Lee JW; Lee JC; Hwang SJ; Kim KC Cells; 2024 Jun; 13(13):. PubMed ID: 38994939 [TBL] [Abstract][Full Text] [Related]
23. Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subjects. Giuffrè GM; Quaranta D; Vita MG; Costantini EM; Citro S; Carrozza C; De Ninno G; Calabresi P; Marra C J Prev Alzheimers Dis; 2024; 11(4):1073-1078. PubMed ID: 39044519 [TBL] [Abstract][Full Text] [Related]
24. Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease. Leitão MJ; Silva-Spínola A; Santana I; Olmedo V; Nadal A; Le Bastard N; Baldeiras I Alzheimers Res Ther; 2019 Nov; 11(1):91. PubMed ID: 31759396 [TBL] [Abstract][Full Text] [Related]
25. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900 [TBL] [Abstract][Full Text] [Related]
26. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting. Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform. Agnello L; Giglio RV; Del Ben F; Piccoli T; Colletti T; Scazzone C; Lo Sasso B; Ciaccio AM; Gambino CM; Salemi G; Ciaccio M Sci Rep; 2024 Jul; 14(1):16084. PubMed ID: 38992063 [TBL] [Abstract][Full Text] [Related]
28. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET. De Meyer S; Schaeverbeke JM; Luckett ES; Reinartz M; Blujdea ER; Cleynen I; Dupont P; Van Laere K; Vanbrabant J; Stoops E; Vanmechelen E; di Molfetta G; Zetterberg H; Ashton NJ; Teunissen CE; Poesen K; Vandenberghe R Brain Commun; 2024; 6(4):fcae162. PubMed ID: 39051027 [TBL] [Abstract][Full Text] [Related]
29. Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease. Inekci D; Henriksen K; Linemann T; Karsdal MA; Habib A; Bisgaard C; Eriksen FB; Vilholm OJ Curr Alzheimer Res; 2015; 12(9):829-36. PubMed ID: 26159200 [TBL] [Abstract][Full Text] [Related]
30. Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays. Lewczuk P; Lelental N; Spitzer P; Maler JM; Kornhuber J J Alzheimers Dis; 2015; 43(1):183-91. PubMed ID: 25079805 [TBL] [Abstract][Full Text] [Related]
31. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related]
32. Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer's pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform. Martínez-Dubarbie F; Guerra-Ruiz A; López-García S; Lage C; Fernández-Matarrubia M; Infante J; Pozueta-Cantudo A; García-Martínez M; Corrales-Pardo A; Bravo M; López-Hoyos M; Irure-Ventura J; Sánchez-Juan P; García-Unzueta MT; Rodríguez-Rodríguez E Alzheimers Res Ther; 2023 Oct; 15(1):163. PubMed ID: 37784138 [TBL] [Abstract][Full Text] [Related]